Clinical trial Recruiting at 1 site Observational Ages 4 to 8

Onset of myopia in children who are not yet myopic

Official title: Incidence of Myopia in a Prospective Cohort of Emmetropic Children and Associated Ocular and Environmental Factors

Run by Fondation Ophtalmologique Adolphe de Rothschild · NCT07316998 · Data updated 2026-11-12

This study follows children aged 4 to under 9 with no myopia to see how many become nearsighted over time and what factors might influence that shift.

Quick facts

Study typeObservational
Ages4 Years to 8 Years
SexAll
Enrollment100 (estimated)
SponsorFondation Ophtalmologique Adolphe de Rothschild
Research network
Locations1 site (Paris)
StatusRecruiting
StartedFebruary 18, 2026
Main results expectedFebruary 2031
Study endsFebruary 2031
Registry record updatedJuly 23, 2026
Trial IDNCT07316998 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 4 to under 9 years with autorefractor-measured spherical equivalent between 0.00 and +2.00 diopters in both eyes and no history of myopia-control therapy or related ocular interventions.

Probably not a fit

Children who already have myopia or have received myopia-control treatments, ocular surgeries, or inflammatory/traumatic eye conditions are unlikely to benefit from this observational follow-up.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study tracks a cohort of emmetropic children over annual follow-ups to identify factors associated with the onset of myopia. Participants are aged 4 to under 9 at enrollment and must have a spherical equivalent between plano and +2.00 diopters in each eye. Data collected may include ocular measurements and environmental factors to understand what contributes to myopia development and to inform future prevention strategies. The trial is sponsored by Fondation Ophtalmologique Adolphe de Rothschild and conducted at Hôpital Fondation A. de Rothschild in Paris. No intervention beyond standard clinical follow-up is planned.

Why it matters

Potential benefit: Identifying risk factors for myopia onset could guide prevention efforts and inform the effectiveness of existing myopia-control strategies in delaying or preventing onset.

How similar studies have gone: Previous epidemiological work has explored risk factors for myopia progression; this study focuses on onset and may be more exploratory and novel in its predictive aims.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 4 years and \< 9 years
* Spherical equivalent measured by autorefractometer ≥ 0.00 and ≤ +2.00 diopters in each eye (cycloplegic autorefraction)

Exclusion Criteria:

* Presence of trauma in at least one eye
* Presence of inflammatory ocular pathology in at least one eye
* History of intraocular pressure-lowering ophthalmic treatment, intravitreal injections, laser treatment, or myopia control therapy (e.g., atropine, orthokeratology, myopia control lenses)
* History of ophthalmic surgery other than for the management of strabismus (e.g., cataract surgery, filtering surgery, intravitreal surgery) in at least one eye

Where it's running

  • Hôpital Fondation A. de Rothschild
    Paris, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.